{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T18:59:13Z","timestamp":1766516353380,"version":"3.45.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.yebeh.2025.110427","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T08:04:56Z","timestamp":1744963496000},"page":"110427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Anti-seizure medication is a minor causative factor in behavioral problems of children with tuberous sclerosis complex"],"prefix":"10.1016","volume":"168","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0122-1174","authenticated-orcid":false,"given":"H.M.","family":"Hulshof","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.K.","family":"Heijstek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.M.","family":"Otte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Bruining","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.P.J.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.E.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.yebeh.2025.110427_b0005","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","article-title":"Neurological and neuropsychiatric aspects of tuberous sclerosis complex","volume":"14","author":"Curatolo","year":"2015","journal-title":"The Lancet Neurology"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110427_b0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13023-019-1258-3","article-title":"A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC)","volume":"15","author":"Z\u00f6llner","year":"2020","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"10.1016\/j.yebeh.2025.110427_b0015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.yebeh.2008.05.010","article-title":"Behavior problems in children with tuberous sclerosis complex and parental stress","volume":"13","author":"Kopp","year":"2008","journal-title":"Epilepsy Behav"},{"issue":"5","key":"10.1016\/j.yebeh.2025.110427_b0020","first-page":"294","article-title":"Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders and Parental Stress: Findings from a National","volume":"50","author":"Ebrahimi-Fakhari","year":"2019","journal-title":"Prospective TSC Surveillance Study Neuropediatrics"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110427_b0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2014.10.004","article-title":"Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist","volume":"52","author":"de Vries","year":"2015","journal-title":"Pediatr Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110427_b0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pediatrneurol.2014.10.006","article-title":"Pilot validation of the tuberous sclerosis-associated neuropsychiatric disorders (TAND) checklist","volume":"52","author":"Leclezio","year":"2015","journal-title":"Pediatr Neurol"},{"issue":"July","key":"10.1016\/j.yebeh.2025.110427_b0035","first-page":"1","article-title":"Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders (TAND): New Findings on Age, Sex, and Genotype in Relation to Intellectual Phenotype","volume":"11","author":"de Vries","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2025.110427_b0040","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1017\/S0033291702007092","article-title":"Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex","volume":"33","author":"Joinson","year":"2003","journal-title":"Psychol Med"},{"key":"10.1016\/j.yebeh.2025.110427_b0045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/jmg.2003.012757","article-title":"Genotype and psychological phenotype in tuberous sclerosis","volume":"41","author":"Lewis","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.yebeh.2025.110427_b0050","doi-asserted-by":"crossref","unstructured":"de Vries PJ, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, Dahlin M, D'Amato L, d'Aug\u00e8res GB, Ferreira JC, Feucht M, Fladrowski C, Hertzberg C, Jozwiak S, Kingswood JC, Lawson JA, Macaya A, Marques R, Nabbout R, O'Callaghan F, Qin J, Sander V, Sauter M, Shah S, Takahashi Y, Touraine R, Youroukos S, Zonnenberg B, Jansen AC; TOSCA Consortium and TOSCA Investigators. TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study. Orphanet J Rare Dis. 2018 Sep 10;13(1):157.","DOI":"10.1186\/s13023-018-0901-8"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110427_b0055","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"International Tuberous Sclerosis Complex Consensus Group.Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2025.110427_b0060","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110427_b0065","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f7450","article-title":"Converting an odds ratio to a range of plausible relative risks for better communication of research findings","volume":"348","author":"Grant","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.yebeh.2025.110427_b0070","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1212\/01.WNL.0000078031.32904.0D","article-title":"Psychiatric adverse events during levetiracetam therapy","volume":"61","author":"Mula","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2025.110427_b0075","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1528-1157.1998.tb01183.x","article-title":"Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation","volume":"39","author":"Ettinger","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110427_b0080","doi-asserted-by":"crossref","unstructured":"Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies. Strzelczyk A, Schubert-Bast S. CNS Drugs. 2022 Oct;36(10):1079-1111.","DOI":"10.1007\/s40263-022-00955-9"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110427_b0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1755-5949.2009.00087.x","article-title":"Neurological and cardiovascular adverse events associated with antimanic treatment in children and adolescents","volume":"16","author":"Jerrell","year":"2010","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.yebeh.2025.110427_b0090","volume":"154","author":"Postma","year":"2024","journal-title":"Understanding neurodevelopmental trajectories and behavioral profiles in SCN1A-related epilepsy syndromes"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505025001660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505025001660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T17:46:15Z","timestamp":1764092775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505025001660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":18,"alternative-id":["S1525505025001660"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2025.110427","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-seizure medication is a minor causative factor in behavioral problems of children with tuberous sclerosis complex","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2025.110427","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110427"}}